Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors

PURPOSE: Thymic epithelial tumors are rare malignancies, and there is no standard treatment for patients with advanced disease in whom chemotherapy has failed. Antitumor activity of histone deacetylase (HDAC) inhibitors in this disease has been documented, including one patient with thymoma treated...

Full description

Saved in:
Bibliographic Details
Main Authors: Giaccone, Giuseppe, Rajan, Arun, Berman, Arlene, Kelly, Ronan J., Szabo, Eva, Lopez-Chavez, Ariel, Trepel, Jane, Lee, Min-Jung, Cao, Liang, Espinoza-Delgado, Igor, Spittler, John, Loehrer, Patrick J.
Format: Artigo
Language:Inglês
Published: American Society of Clinical Oncology 2011
Subjects:
Original Reports
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3107761/
https://ncbi.nlm.nih.gov/pubmed/21502553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.32.4467
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items